Yun Gong
Executive Director, Strategic Partnerships & General Manager, Innorna Platform Innorna
Yun Gong leads Innorna’s strategic partnerships and platform, shaping collaborations at the intersection of RNA medicines and LNP delivery. She brings more than a decade of experience in genomic medicine delivery, spanning product management, strategy, and scientific research. Yun has guided crossfunctional teams to launch dozens of delivery products, service offerings, and outlicensing initiatives with global reach. Her background also includes management roles in corporate strategy, M&A and integration, portfolio and project management, commercial operations, and business analysis across organizations serving the worldwide life science community.
Seminars
- NHP data demonstrating the potential of targeted mRNA‑LNPs to enable in vivo immunotherapy for autoimmune disease models
- Robust B‑cell depletion across peripheral blood, spleen, and lymphoid tissues using a proprietary targeted LNP delivery platform
- Evidence of immune‑reset biology with emerging safety and tolerability supporting continued preclinical development
NEW DATA
